Figure 1From: Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)Prothrombin time following a single oral dose of warfarin sodium and multiple oral doses of riociguat or placebo.Back to article page